Peregrine Capital Management LLC Reduces Position in AdaptHealth Corp. (NASDAQ:AHCO)

Peregrine Capital Management LLC lessened its stake in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 5.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 555,019 shares of the company's stock after selling 30,186 shares during the period. Peregrine Capital Management LLC owned approximately 0.41% of AdaptHealth worth $6,016,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the stock. Assetmark Inc. bought a new stake in shares of AdaptHealth during the 4th quarter worth $28,000. GAMMA Investing LLC raised its position in AdaptHealth by 175.2% during the first quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock valued at $81,000 after purchasing an additional 4,758 shares in the last quarter. Guggenheim Capital LLC raised its position in AdaptHealth by 10.1% during the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock valued at $158,000 after purchasing an additional 1,525 shares in the last quarter. KLP Kapitalforvaltning AS bought a new stake in AdaptHealth during the fourth quarter worth about $169,000. Finally, Humankind Investments LLC boosted its holdings in shares of AdaptHealth by 18.3% in the 4th quarter. Humankind Investments LLC now owns 17,979 shares of the company's stock worth $171,000 after purchasing an additional 2,776 shares in the last quarter. Institutional investors own 82.67% of the company's stock.

AdaptHealth Trading Down 4.2%

NASDAQ AHCO traded down $0.39 during trading on Friday, hitting $8.98. 800,457 shares of the company's stock traded hands, compared to its average volume of 1,323,489. The stock has a fifty day moving average of $8.83 and a two-hundred day moving average of $9.44. AdaptHealth Corp. has a 12-month low of $7.11 and a 12-month high of $11.90. The firm has a market cap of $1.21 billion, a P/E ratio of 15.76, a PEG ratio of 1.08 and a beta of 1.63. The company has a debt-to-equity ratio of 1.25, a current ratio of 1.29 and a quick ratio of 1.07.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on AHCO. Royal Bank Of Canada decreased their price objective on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a report on Thursday, May 8th. Truist Financial reduced their price target on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday, May 12th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $13.40.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.